Unconventional T Cell Immunity in the Lungs of Young Children with Cystic Fibrosis

Rebecca McElroy1, Ghazal Alipour Talesh1,2, Christopher M Harpur1

  • 1Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, 3052 Victoria, Australia.

Insights

In young children with Cystic Fibrosis (CF), viral infections significantly increase Natural Killer T (NKT)-like cells in the lungs. This highlights early immune responses in CF, particularly T cell interactions with viral pathogens.

Area of Science:

  • Immunology
  • Pediatric Pulmonology
  • Cellular Biology

Background:

  • Cystic Fibrosis (CF) causes early lung inflammation, infection, and damage in infants and children.
  • Early immune responses, especially T cell activity, are critical in CF progression but remain understudied in early disease stages.
  • The role of T cell subsets in the developing CF lung is poorly understood.

Purpose of the Study:

  • To investigate T cell subsets in the lungs of young children with CF.
  • To analyze the impact of age, sex, and infections on T cell populations in early CF.
  • To explore potential interactions between T cells and viral pathogens in pediatric CF.

Main Methods:

  • Bronchoalveolar lavage (BAL) samples were collected from 17 children (2-6 years old) with CF.
  • Flow cytometry was used to analyze Mucosal Associated Invariant T (MAIT) cells, γδ T cells, and Natural Killer T (NKT)-like cells.
  • Statistical analyses (t-test, Kruskal-Wallis) assessed the effects of age, sex, and infection status.

Main Results:

  • No significant differences in T cell subset proportions were found related to the children's age or sex.
  • Frequencies of γδ T cells and MAIT cells were not significantly altered by infection status.
  • Viral infections were associated with a significant increase in the proportion of NKT-like cells in the BAL samples.

Conclusions:

  • Early-stage T cell evaluation in pediatric CF lungs reveals potential interactions with viral pathogens.
  • Increased NKT-like cells during viral infections suggest a specific immune response in young CF patients.
  • Further research into these early immune events is crucial for understanding CF disease burden.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
378
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
466
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
229
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
74.4K